Market Place
Sourcing Support
FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy
31 Jul 2023 //
GLOBENEWSWIRE
Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors
13 Jul 2023 //
GLOBENEWSWIRE
INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE
05 Jan 2023 //
GLOBENEWSWIRE
Updated Invectys and CTMC announce FDA clearance of IND application
20 Dec 2022 //
GLOBENEWSWIRE
Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T
19 Dec 2022 //
GLOBENEWSWIRE
Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy
16 Jun 2022 //
GLOBENEWSWIRE
Invectys appoints Timothy Papp as its Chief Financial Officer
12 May 2022 //
GLOBENEWSWIRE
Invectys Appoints Franois Lescure as General Manager of its R&D Subsidiary
11 Apr 2022 //
GLOBENEWSWIRE
Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development
01 Mar 2022 //
GLOBENEWSWIRE
Invectys To Participate In 2021 Roth Virtual Healthcare Private Company Forum
25 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.